Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.

about

Recent Advances in Biomarkers for Parkinson's Disease Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure

P2860

Q58572579-1D843DDA-2A49-4602-836E-7EE7741D6D55 Q59137487-ED9FB618-60BF-4AD2-9C9F-249B3C589943

P2860

Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.

Item

http://www.wikidata.org/entity/Q43690639

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Serum IGF-1 is associated with ...... rug-naïve Parkinson's disease.

@en

Serum IGF-1 is associated with ...... rug-naïve Parkinson's disease.

@nl

type

Item

label

Serum IGF-1 is associated with ...... rug-naïve Parkinson's disease.

@en

Serum IGF-1 is associated with ...... rug-naïve Parkinson's disease.

@nl

prefLabel

Serum IGF-1 is associated with ...... rug-naïve Parkinson's disease.

@en

Serum IGF-1 is associated with ...... rug-naïve Parkinson's disease.

@nl

P1476

Serum IGF-1 is associated with ...... rug-naïve Parkinson's disease.

@en

P2093

Angela Pierro

http://www.w3.org/2001/XMLSchema#string

Claudia Pivonello

http://www.w3.org/2001/XMLSchema#string

Renata Auriemma

http://www.w3.org/2001/XMLSchema#string

Riccardo Savastano

http://www.w3.org/2001/XMLSchema#string

Sara Scannapieco

http://www.w3.org/2001/XMLSchema#string

P2860

Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson's Disease: A Meta-Analysis

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Neuroimaging studies of working memory: a meta-analysis.

A fMRI study of word retrieval in aphasia.

Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

Toward a comprehensive neurobiology of IGF-I.

Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease

Insulin-like growth factor-I, cognition and brain aging.

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease.

P304

e0186508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0186508

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Teresa Pellecchia

Marianna Amboni

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29065116

http://www.w3.org/2001/XMLSchema#string

P932

5655531

http://www.w3.org/2001/XMLSchema#string

Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.

about

P2860

P2860

Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932